IL6 and hepatocellular carcinoma: A previous study reported that macrophages in the early stage of HCC express high levels of major histocompatibility complex (MHC)-class II and cytokines, such as IL-1β, IL-6, IL-12, and inducible nitric oxide synthase, which suppress tumor progression.